SiRNA-mediated survivin inhibition enhances chemo- or radiosensivity of colorectal cancer cells in tumor-bearing nude mice

Hepato-Gastroenterology

Volumn 57, Issue 104, 2010, Pages 1445-1452

  Chu, Xiaoyuan ^a   Chen, Longbang ^a   Wang, Jinghua ^a   Guan, Xiaoxiang ^a   Geng, Huaicheng ^a   Zhang, Qun ^a   Song, Haizhu ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Chemosemsitiviy; Colorectal cancer; Radiosensitivity; RNA interference; siRNA; Suvivin

Indexed keywords

CASPASE 3; FLUOROURACIL; MESSENGER RNA; PLASMID VECTOR; SHORT HAIRPIN RNA; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER SIZE; CELL PROLIFERATION; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; MULTIMODALITY CANCER THERAPY; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SILENCER GENE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, NUDE; PLASMIDS; RADIATION TOLERANCE; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SILENCER ELEMENTS, TRANSCRIPTIONAL; TUMOR CELLS, CULTURED;

EID: 79952390612     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Shelton BK: Introduction to colorectal cancer. Semin Oncol Nurs 2002; 18:2-12.
3. Vanhoefer U: Molecular mechanisms and targeting of colorectal cancer. Semin Oncol 2005; 32:7-10.
4. Mita AC, Mita MM, Nawrocki ST, et al: Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008; 14:5000-5005.
5. Altieri DC, Marchisio PC: Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 1999; 79:1327-1333.
6. Ryan BM, O'Donovan N, Duffy MJ: Survivin: a new target for anti-cancer therapy.Cancer Treat Rev 2009; 35:553-562.
7. Zhang YC, Taylor MM, Samson WK, et al: Antisense inhibition: oligonucleotides, ribozymes, and siRNAs. Meth Mol Med 2005; 106:11-34.
8. Xiaoyuan C, Longbang C, Jinghua W, et al: Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer. Ir J Med Sci. 2009 Nov 17. [Epub ahead of print]
9. Wang YG, Chen KX, Wu GL, et al: An analysis: colon cancer mortality in Tianjin, China, from 1981 to 2000. World J Gastroenterol 2005;11:895-8.
10. rd: Adjuvant therapy for colon cancer. Curr Gastroenterol Rep 2007; 9:415-421.
11. Wheatley SP, McNeish IA: Survivin: a protein with dual roles in mitosis and apoptosis. Int Rev Cytol 2005; 247:35-88. (Pubitemid 41774364)
12. Lotocki G, Keane RW: Inhibitors of apoptosis proteins in injury and disease. IUBMB Life 2002; 54:231-240. (Pubitemid 36176833)
13. LaCasse EC, Baird S, Korneluk RG, et al: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998; 17:3247-3259. (Pubitemid 29043977)
14. Lin LJ, Zheng CQ, Jin Y, et al: Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol 2003; 9:974-977. (Pubitemid 36681663)
15. Chen WC, Liu Q, Fu JX, et al: Expression of survivin and its significance in colorectal cancer. World J Gastroenterol 2004; 10:2886-2889. (Pubitemid 39303012)
16. Liang QL, Wang BR, Li GH: DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters. J Zhejiang Univ Sci B 2009; 10:675-682.
17. Zamparese R, Pannone G, Santoro A, et al: Survivin expression in renal cell carcinoma. Cancer Invest 2008; 26:929-935.
18. Chau GY, Lee AF, Tsay SH, et al: Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma. Histopathology 2007; 51:204-218. (Pubitemid 47083982)
19. Nakano J, Huang C, Liu D, Masuya D, et al: The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers. Br J Cancer 2008; 98:1109-1117. (Pubitemid 351399801)
20. Cheng Z, Hu L, Fu W, et al: Expression of survivin and its splice variants in gastric cancer. J Huazhong Univ Sci Technolog Med Sci 2007; 27:393-398.
21. Nouraee N, Mowla SJ, Ozhand A, et al: Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Urol J 2009; 6:101-108.
22. Koike H, Sekine Y, Kamiya M, et al: Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer. Urology 2008; 72:1229-1233.
23. Harfouche R, Hassessian HM, GuoY, et al: Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc Res 2002; 64:135-147. (Pubitemid 34713240)
24. Li W, Wang X, Lei P, et al: Antisense RNA of survivin gene inhibits the proliferation of leukemia cells and sensitizes leukemia cell line to taxol-induced apoptosis. J Huazhong Univ Sci Technolog Med Sci 2008; 28:1-5.
25. Yang CT, Li JM, Weng HH, et al: Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells. Cancer Gene Ther 2010; 17:120-130.
26. Liu WS, Yan HJ, Qin RY, et al: siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity. Dig Dis Sci 2009; 54:89-96.
27. Yang H, Fu JH, Hu Y, et al: Influence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells. J Int Med Res 2008; 36:734-747.
28. Liu F, Xie ZH, Cai GP, et al: The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells. Biol Pharm Bull 2007; 30:2279-2283. (Pubitemid 350223727)
29. Kami K, Doi R, Koizumi M, et al: Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. Surgery 2005; 138:299-305. (Pubitemid 41253814)
30. Guan HT, Xue XH, Dai ZJ, et al: Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radio-sensitivity. World J Gastroenterol 2006; 12:2901-2907.